Versions of the Application
Additional Forms
Special Considerations for All Applications
How to Submit Your Application to the IRB
Different versions of the application form exist with three specific research types in mind. There are three flavors of the Application for Review; Interventional, Observational, Human Specimen and Data Research (No Subject Contact). Choose the version of the Application for Review which best fits the type of research you are conducting. The application forms will guide you to what type of IRB review you will need as represented by the bands below.
Additional documents may be required, depending on the activity. The application form will prompt for these additional documents to be attached as part of the application package for the IRB to review.
Applications for Review
External IRB Cover Sheet - New Application
NOTE: If the collection of biospecimens or information also involves an intervention, use the Interventional Research version of the IRB application.
NOTE: If the collection of data or specimens also involves interaction with a human, use the Observational or Interventional version of the IRB application.
Additional forms and supplements which may be required as directed in the Application form.
Forms and supplements can be found in Forms Central.
Clinical intervention involving cancer or relating to cancer: Studies involving clinical intervention may need review by Scientific Review Committee (SRC). If you need assistance in determining whether your study requires review by either of these two Committees, please contact Clinical Research Support at 206.667.4520.
University of Washington Cancer Consortium studies: For questions regarding the Cancer Consortium IRB and/or the submission process, please go to the Cancer Consortium website. Additionally, investigators submitting a UW Cancer Consortium application must first request authorization from UW HSD to rely on the Fred Hutch IRB. UW investigators can complete the REQUEST: External IRB Review form to initiate this request through UW.
Seattle Children’s: For questions regarding the Cancer Consortium IRB and/or the submission process, please go to the Cancer Consortium website. Additionally, when Seattle Children’s is an institution engaged in the research, the investigator must include an Acknowledgement of Reliance on an External IRB Letter from Seattle Children’s with the submission to the Fred Hutch IRB. Seattle Children’s investigators can initiate this request by making an External IRB submission in the Seattle Children’s Click IRB system.
IND/IDE: If you need assistance in determining whether your study requires an IND or IDE, please contact Regulatory Affairs at 206.667.4520.
Accessing Protected Health Information (PHI) from Seattle Children's: Studies accessing/using/creating/sharing PHI from Seattle Children's must submit a Seattle Children's HIPAA form. Please go to the Seattle Children's website to download the form.
Certificate of Confidentiality: Studies collecting information that if disclosed, could have negative consequences to the participants' financial statuses, employability, insurability or reputation, a Certificate of Confidentiality issued by the National Institutes of Health (NIH) may be required. For more information about Certificate of Confidentiality, please go to the NIH website.
Radiation Safety Review Requirements: If your study involves radiation procedures, please go to the Radiation Safety Review webpage to determine whether Radiation Safety Committee review is required.
Institutional Biosafety Review Requirements: If your study involves the introduction of recombinant DNA or RNA into humans, the application will automatically undergo Full Review and Institutional Biosafety Review will be required.
Submit original documents only.
All documents must be single-sided. Please do not use staples. It is recommended that you keep a complete set of the documents submitted to the IRB for your records.
Once the application receives final approval, the IRO will forward one copy of the stamped approved documents to the person identified on the application as the Contact Person. For research managed through the Fred Hutch Clinical Research Support, approved documents will be returned to the CRS Protocol Review Coordinator.
View a current listing of the IRB submission deadlines and meeting dates.
Please contact the IRO if you have any questions regarding this paperwork. We are prepared to assist anyone who may need advice. Your cooperation in all of these matters is much appreciated and helps to process your materials more rapidly.